DDR/FAM107A-directed ASOs conjugated to the GSC antigens CD44 or EphA2 successfully decreased glial stem cell proliferation and self-renewal, which is a key indicator of malignancy in GBM [17]. Here, FAM107A is linked to glioblastoma.